Tumor Hyperinsulinism (Tumor HI)
Oncology·MeSH: Hyperinsulinism
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ersodetug | Rezolute, Inc. (RZLT) |
Frequently asked questions
How many drugs are in development for Tumor Hyperinsulinism (Tumor HI)?
BioSniper tracks 1 drug in development for Tumor Hyperinsulinism (Tumor HI) across 1 company.
How many clinical trials target Tumor Hyperinsulinism (Tumor HI)?
There are 1 clinical trial targeting Tumor Hyperinsulinism (Tumor HI) tracked by BioSniper.
Deep-dive into Tumor Hyperinsulinism (Tumor HI)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis